NCT05868603 is a NA clinical trial of Remineralization gel in White Spot Lesion, sponsored by Marmara University.

Who is sponsoring NCT05868603?

NCT05868603 is sponsored by Marmara University.

What drugs are being tested in NCT05868603?

Interventions in NCT05868603: Remineralization gel.

What condition does NCT05868603 study?

NCT05868603 studies White Spot Lesion.

Is NCT05868603 still recruiting?

NCT05868603 is currently status unknown. Last updated 22 May 2023.

Last reviewed 2023-05-22 · How we verify

NCT05868603

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Different Remineralization Gels

Status unknown NA Last updated 22 May 2023

What this trial tests

NA trial testing Remineralization gel in White Spot Lesion in 45 participants. Status unknown.

Timeline

24 May 2023

Primary endpoint
1 October 2024

1 April 2025

Quick facts

Lead sponsor	Marmara University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	24 May 2023
Primary completion	1 October 2024
Estimated completion	1 April 2025

Drugs / interventions tested

Remineralization gel

Conditions studied

White Spot Lesion — all drugs for White Spot Lesion →

Sponsor

Marmara University

Who can join

Adults 15 to 18, any sex, with White Spot Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to treat white spot lesions that occur after orthodontic treatment. Different gels will be used for remineralization. The study will consist of 45 people between the ages of 15-18. 45 people will be divided into 3 groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for White Spot Lesion

Currently open trials in the same condition.

NCT07319884 — The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled S · NA · active not recruiting

Other Marmara University trials

Trials by the same sponsor.

NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05868603 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marmara University
Last refreshed: 22 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05868603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing